Tagip

Product Search

Tagip Product Information Leaflets
Brand Name:
TAGIP
Generic Name:
Sitagliptin

DESCRIPTION:

TAGIP tablet contains Sitagliptin Phosphate, an orallyactive inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme.

COMPOSITION:

TAGIP 25 mg tablets: Each film coated tablet contains: Sitagliptin (as phosphate) 25 mg. TAGIP 50 mg tablets: Each film coated tablet contains: Sitagliptin (as phosphate) 50 mg. TAGIP 100 mg tablets: Each film coated tablet contains: Sitagliptin (as phosphate) 100 mg.

INDICATIONS:

TAGIP (Sitagliptin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus either as monotherapy or in combination therapy. TAGIP (Sitagliptin) should not be used in type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.

DOSAGE & ADMINISTRATION:

The recommended dose of Tagip is 100mg once daily. Sitagliptin can be taken with or without food. 100mg once daily for patients with mild renal impairment (creatinine clearance 50ml/min or more); no adjustment is necessary. 50mg once daily patients with moderate renal impairment (creatinine clearance less than 50ml/min). 25 mg once daily in patients with severe renal impairment (creatinine clearance less than 30ml/min); or end stage renal disease requiring haemodialysis or peritoneal dialysis, It may be given without regard to the timing of haemodialysis.

CONTRAINDICATIONS:

TAGIP is contraindicated in patients with; Hypersensitivity to the active substance or to any of the excipients. Type 1 diabetes mellitus or for the treatment of ketoacidosis.

PRESENTATION:

TAGIP25 mg tablets: Blister pack of 2 x 7's tablet. TAGIP50 mg tablets: Blister pack of 2 x 7's tablet. TAGIP100 mg tablets: Blister pack of 2 x 7's tablet.

Patients should consult with their physician before taking any medicine.